Johnson & Johnson

JNJ · Pharmaceutical Preparations · $650.6B
Powering up
JNJ
$269.99
▼ −0.09%
09/18 O 269.45 H 272.11 L 267.20 C 269.99 ▼ −0.09%
Vol 16.4M RS 76
RS rating76
Now vs pivot (%)+7.26%
Tightening (ATR ratio)0.99×
Volume dry-up0.95×
Up/down volume, net0.19
From 52-week high4%
coolingclimbing
Previous breakout trailed out ▲ +7.65% in Jan
Powering up
Moving averages
9-dayabout two weeks21-dayabout a month50-dayabout a quarter200-dayabout a year

The four are not in order. That is a description of where the averages sit, not a view about what happens next.

The read

The base has run 16.2 weeks and fell 12% from its ceiling at its deepest. The pivot is $251.71, and the stock closed 7.3% above that pivot. Its relative strength rating is 76.

Also on
Peers
Catalyst roadmap
  1. Earningstentativein 25d
    Quarterly earnings
    Oct 13, 2026
  2. EarningstentativeLLY · competitorin 41d
    LLY reports
    Oct 29, 2026
  3. EarningstentativeAAPL · industryin 41d
    AAPL reports
    Oct 29, 2026
Flagged by the market sweep

Nothing flagged for this company on the last market sweep.

In the news
Insiders

No Form 4 filings read for this company in the last six months. That can mean nobody filed, or that this name has not been on a screen long enough for us to have fetched them.

X-ray

A screening and market-analytics tool. Not investment advice. We are not a registered investment adviser. Historical figures are backtests and are hypothetical.

What that means, in full
Johnson & Johnson (JNJ) — The Tape